Delivery Order SPE2DE21D7009-SPE2D626F36MD
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $2,681.80 on December 19, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of March 2, 2026, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded through the Medical Supply Chain, a defense-related procurement...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $1,825.75 on November 28, 2025, for pain management medical devices and services. This fixed-price delivery order with economic price adjustment authority is performance-based in Valencia, California, and carries an ultimate completion date of December 5, 2025. The contract was awarded by the Medical Supply Chain, a defense-related procurement entity under the Department of...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,867.00 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment authority has an ultimate completion date of February 6, 2026, and will be performed in Valencia, California. The award was made without a set-aside designation by the Medical Supply Chain, a defense-related procurement entity within...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $36,654.68 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of December 29, 2025 and will be performed in Valencia, California. The award is issued under a larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,798.00 on November 28, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of December 5, 2025 and will be performed in Valencia, California. The award was issued by the Medical Supply Chain, a Defense-related procurement entity within the federal government, with no small...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $1,825.75 delivery order for pain management medical devices under contract 4570282591. The award, issued on November 28, 2025, with an ultimate completion date of December 5, 2025, utilizes a fixed-price contract with economic price adjustment pricing structure. The contract is not designated for any small business set-aside and will be performed in Valencia, California. This delivery order...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $31,771.22 fixed-price delivery order (Contract No. 4570331497) on December 15, 2025, for pain management medical devices and related services. The award carries an economic price adjustment clause and is scheduled for completion by December 29, 2025. This delivery order was issued under the company's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $41,430.34 for pain management medical devices and services. This fixed-price contract with economic price adjustment was awarded on September 9, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Valencia, California. The award carries no set-aside designation, allowing the company to compete openly in the federal marketplace....
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F36MDDelivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, received a delivery order award valued at $1,891.76 on December 19, 2025, for pain management medical devices and services. The contract is a fixed-price delivery order with economic price adjustment provisions, with an ultimate completion date of December 29, 2025. Work will be performed in Valencia, California. This delivery order is issued under the company's larger indefinite delivery contract with the Defense Logistics Agency Troop Support Medical branch, valued at $83.1 million through August 16, 2026, which enables Boston Scientific Neuromodulation to provide comprehensive neuromodulation solutions including spinal cord stimulation systems, implantable pain pumps, and associated accessories. The funding source is the Medical Supply Chain, a defense-related procurement entity supporting Department of Defense and Department of Veterans Affairs healthcare needs. This award carries no small business set-aside designation, allowing Boston Scientific to compete on an unrestricted basis. The company specializes in non-opioid pain management technologies, including proprietary spinal cord stimulators such as the RestoreSensor and Spectra WaveWriter systems, designed to support military treatment facilities and VA medical centers in managing chronic pain resulting from traumatic injuries. Boston Scientific's federal portfolio extends beyond neuromodulation to include cardiovascular devices, radiation treatment systems, and cardiac care equipment, positioning the company as a significant supplier of specialized medical technologies across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/18/25 |